Amanote Research

Amanote Research

  • Register
  • Sign In

Tivozanib in the Treatment of Renal Cell Carcinoma

Biologics: Targets and Therapy- New Zealand

doi 10.2147/btt.s32958

Full Text

Abstract

Available in

Categories

OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy

Date

June 1, 2013

Authors

Mehmet Hepgur

Publisher

Informa UK Limited


Related search

Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2016English

Nivolumab in the Treatment of Advanced Renal Cell Carcinoma

Oncology in Clinical Practice
Oncology
2019English

Nivolumab in Treatment of Renal Cell Carcinoma During Renal Replacement Therapy

Oncology in Clinical Practice
Oncology
2019English

Profile of Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2010English

M-Tor Inhibitors in the Treatment of Advanced Renal Cell Carcinoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2011English

New Systemic Approaches in the Treatment of Metastatic Renal Cell Carcinoma

2012English

Trend of Surgical Treatment of Localized Renal Cell Carcinoma

Permanente journal,The
Medicine
2019English

Nonablative Hematopoietic Cell Transplantation for the Treatment of Metastatic Renal Cell Carcinoma

Bone Marrow Transplantation
TransplantationHematology
2002English

Everolimus &Ndash; A New Approach in the Treatment of Renal Cell Carcinoma

Cancer Management and Research
Oncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy